{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T15:58:13Z","timestamp":1772726293203,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,5]]},"DOI":"10.7759\/cureus.104712","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T14:55:49Z","timestamp":1772722549000},"source":"Crossref","is-referenced-by-count":0,"title":["Prescribing Practices, Motivations, and Behaviors Contributing to Prescription Stimulant Misuse Among Medical Students at an Allopathic Medical School: Cross-Sectional Survey Study"],"prefix":"10.7759","author":[{"given":"Hannah B","family":"Short","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Lehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sruthi","family":"Nelluri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Latronica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhavna","family":"Bali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2018.02.001","article-title":"The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit\/hyperactivity disorder and other psychiatric comorbidities","volume":"87","author":"Faraone SV","year":"2018","unstructured":"Faraone SV. The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit\/hyperactivity disorder and other psychiatric comorbidities. Neurosci Biobehav Rev. 2018, 87:255-70. 10.1016\/j.neubiorev.2018.02.001","journal-title":"Neurosci Biobehav Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(18)30269-4","article-title":"Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: A systematic review and network meta-analysis","volume":"5","author":"Cortese S","year":"2018","unstructured":"Cortese S, Adamo N, Del Giovane C, et al.. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: A systematic review and network meta-analysis. Lancet Psychiatry. 2018, 5:727-38. 10.1016\/S2215-0366(18)30269-4","journal-title":"Lancet Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2023.4126","article-title":"Long-term cardiovascular effects of medications for attention-deficit\/hyperactivity disorder- balancing benefits and risks of treatment","volume":"81","author":"Cortese S","year":"2024","unstructured":"Cortese S, Fava C. Long-term cardiovascular effects of medications for attention-deficit\/hyperactivity disorder- balancing benefits and risks of treatment. JAMA Psychiatry. 2024, 81:123-4. 10.1001\/jamapsychiatry.2023.4126","journal-title":"JAMA Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.0851","article-title":"ADHD pharmacotherapy and mortality in individuals with ADHD","volume":"331","author":"Li L","year":"2024","unstructured":"Li L, Zhu N, Zhang L, et al.. ADHD pharmacotherapy and mortality in individuals with ADHD. JAMA. 2024, 331:850-60. 10.1001\/jama.2024.0851","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2261-12-41","article-title":"Do prescription stimulants increase the risk of adverse cardiovascular events?: A systematic review","volume":"12","author":"Westover AN","year":"2012","unstructured":"Westover AN, Halm EA. Do prescription stimulants increase the risk of adverse cardiovascular events?: A systematic review. BMC Cardiovasc Disord. 2012, 12:41. 10.1186\/1471-2261-12-41","journal-title":"BMC Cardiovasc Disord"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.78","article-title":"Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: Misuse, cognitive impact, and adverse effects","volume":"2","author":"Lakhan SE","year":"2012","unstructured":"Lakhan SE, Kirchgessner A. Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: Misuse, cognitive impact, and adverse effects. Brain Behav. 2012, 2:661-77. 10.1002\/brb3.78","journal-title":"Brain Behav"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-013-0375-2","article-title":"Stimulant prescription cautions: Addressing misuse, diversion and malingering","volume":"15","author":"Rabiner DL","year":"2013","unstructured":"Rabiner DL. Stimulant prescription cautions: Addressing misuse, diversion and malingering. Curr Psychiatry Rep. 2013, 15:375. 10.1007\/s11920-013-0375-2","journal-title":"Curr Psychiatry Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0206100","article-title":"Trends in use of prescription stimulants in the United States and Territories, 2006 to 2016","volume":"13","author":"Piper BJ","year":"2018","unstructured":"Piper BJ, Ogden CL, Simoyan OM, Chung DY, Caggiano JF, Nichols SD, McCall KL. Trends in use of prescription stimulants in the United States and Territories, 2006 to 2016. PLoS One. 2018, 13:e0206100. 10.1371\/journal.pone.0206100","journal-title":"PLoS One"},{"key":"ref9","article-title":"Monitoring the Future national survey results on drug use, 1975-2020: Volume II, college students and adults ages 19-60","volume":"2","author":"Schulenberg JE","year":"2021","unstructured":"Schulenberg JE, Patrick ME, Johnston LD, et al.. Monitoring the Future national survey results on drug use, 1975-2020: Volume II, college students and adults ages 19-60. University of Michigan Institute for Social Research. 2021, 2:","journal-title":"University of Michigan Institute for Social Research"},{"key":"ref10","article-title":"Key substance use and mental health indicators in the United States: Results from the 2020 national survey on drug use and health","author":"Substance Abuse and Mental Health Services Administration","year":"2021","unstructured":"Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: Results from the 2020 national survey on drug use and health. U.S. Department of Health and Human Services, Rockville, MD; 2021."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2010.509273","article-title":"Nonmedical prescription stimulant use among college students: Why we need to do something and what we need to do","volume":"29","author":"Arria AM","year":"2010","unstructured":"Arria AM, DuPont RL. Nonmedical prescription stimulant use among college students: Why we need to do something and what we need to do. J Addict Dis. 2010, 29:417-26. 10.1080\/10550887.2010.509273","journal-title":"J Addict Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/psychiatryint3030018","article-title":"Prescription stimulants in college and medical students: A narrative review of misuse, cognitive impact, and adverse effects","volume":"3","author":"Edinoff A","year":"2022","unstructured":"Edinoff A, Nix CA, McNeil SE, et al.. Prescription stimulants in college and medical students: A narrative review of misuse, cognitive impact, and adverse effects. Psychiatry Int. 2022, 3:221-235. 10.3390\/psychiatryint3030018","journal-title":"Psychiatry Int"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ap.34.3.220","article-title":"Prevalence of ADHD diagnosis and nonmedical prescription stimulant use in medical students","volume":"34","author":"Tuttle JP","year":"2010","unstructured":"Tuttle JP, Scheurich NE, Ranseen J. Prevalence of ADHD diagnosis and nonmedical prescription stimulant use in medical students. Acad Psychiatry. 2010, 34:220-3. 10.1176\/appi.ap.34.3.220","journal-title":"Acad Psychiatry"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.15163","article-title":"Stimulant usage by medical students for cognitive enhancement: A systematic review","volume":"13","author":"Plumber N","year":"2021","unstructured":"Plumber N, Majeed M, Ziff S, Thomas SE, Bolla SR, Gorantla VR. Stimulant usage by medical students for cognitive enhancement: A systematic review. Cureus. 2021, 13:e15163. 10.7759\/cureus.15163","journal-title":"Cureus"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7556\/jaoa.2014.129","article-title":"Nonmedical use of stimulants among medical students","volume":"114","author":"Wasserman JA","year":"2014","unstructured":"Wasserman JA, Fitzgerald JE, Sunny MA, Cole M, Suminski RR, Dougherty JJ. Nonmedical use of stimulants among medical students. J Am Osteopath Assoc. 2014, 114:643-53. 10.7556\/jaoa.2014.129","journal-title":"J Am Osteopath Assoc"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2020.1732762","article-title":"Prevalence of ADHD symptom malingering, nonmedical use, and drug diversion among college-enrolled adults with a prescription for stimulant medications","volume":"38","author":"Ramachandran S","year":"2020","unstructured":"Ramachandran S, Dertien D, Bentley SI. Prevalence of ADHD symptom malingering, nonmedical use, and drug diversion among college-enrolled adults with a prescription for stimulant medications. J Addict Dis. 2020, 38:176-85. 10.1080\/10550887.2020.1732762","journal-title":"J Addict Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101524","article-title":"Trends in characteristics of the recipients of new prescription stimulants between years 2010 and 2020 in the United States: An observational cohort study","volume":"50","author":"Brumbaugh S","year":"2022","unstructured":"Brumbaugh S, Tuan WJ, Scott A, Latronica JR, Bone C. Trends in characteristics of the recipients of new prescription stimulants between years 2010 and 2020 in the United States: An observational cohort study. EClinicalMedicine. 2022, 50:101524. 10.1016\/j.eclinm.2022.101524","journal-title":"EClinicalMedicine"},{"key":"ref18","article-title":"Attention deficit hyperactivity disorder","author":"Magnus W","year":"2023","unstructured":"Magnus W, Nazir S, Anilkumar A, Shaban K. Attention deficit hyperactivity disorder. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1037\/pas0000702","article-title":"Assessing ADHD in college students: Integrating multiple evidence sources with symptom and performance validity data","volume":"31","author":"Nelson JM","year":"2019","unstructured":"Nelson JM, Lovett BJ. Assessing ADHD in college students: Integrating multiple evidence sources with symptom and performance validity data. Psychol Assess. 2019, 31:793-804. 10.1037\/pas0000702","journal-title":"Psychol Assess"},{"key":"ref20","article-title":"ADHD diagnostic trends: Increased recognition or overdiagnosis?","volume":"119","author":"Abdelnour E","year":"2022","unstructured":"Abdelnour E, Jansen MO, Gold JA. ADHD diagnostic trends: Increased recognition or overdiagnosis?. Mo Med. 2022, 119:467-73.","journal-title":"Mo Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.5335","article-title":"Overdiagnosis of Attention-Deficit\/Hyperactivity Disorder in children and adolescents: A systematic scoping review","volume":"4","author":"Kazda L","year":"2021","unstructured":"Kazda L, Bell K, Thomas R, McGeechan K, Sims R, Barratt A.  Overdiagnosis of Attention-Deficit\/Hyperactivity Disorder in children and adolescents: A systematic scoping review. JAMA Netw Open. 2021, 4:e215335. 10.1001\/jamanetworkopen.2021.5335","journal-title":"JAMA Netw Open"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13111522","article-title":"Attention Deficit Hyperactivity Disorder misdiagnosis: Why medical evaluation should be a part of ADHD assessment","volume":"13","author":"Sadek J","year":"2023","unstructured":"Sadek J. Attention Deficit Hyperactivity Disorder misdiagnosis: Why medical evaluation should be a part of ADHD assessment. Brain Sci. 2023, 13:1522. 10.3390\/brainsci13111522","journal-title":"Brain Sci"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4103\/ipj.ipj_224_21","article-title":"Well-being and burnout in medical students","volume":"30","author":"Bhugra D","year":"2021","unstructured":"Bhugra D, Molodynski A, Ventriglio A. Well-being and burnout in medical students. Ind Psychiatry J. 2021, 30:193-7. 10.4103\/ipj.ipj_224_21","journal-title":"Ind Psychiatry J"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.10544","article-title":"Prevalence of self-disclosed disability among medical students in US allopathic medical schools","volume":"316","author":"Meeks LM","year":"2016","unstructured":"Meeks LM, Herzer KR. Prevalence of self-disclosed disability among medical students in US allopathic medical schools. JAMA. 2016, 316:2271-2. 10.1001\/jama.2016.10544","journal-title":"JAMA"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10214836","article-title":"An evaluation of the performance of five burnout screening tools: A multicentre study in anesthesiology, intensive care, and ancillary staff","volume":"10","author":"Ong J","year":"2021","unstructured":"Ong J, Lim WY, Doshi K, Zhou M, Sng BL, Tan LH, Ong S. An evaluation of the performance of five burnout screening tools: A multicentre study in anesthesiology, intensive care, and ancillary staff. J Clin Med. 2021, 10:4836. 10.3390\/jcm10214836","journal-title":"J Clin Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.acap.2019.06.002","article-title":"Stimulant diversion risk among college students treated for ADHD: Primary care provider prevention training","volume":"20","author":"Molina BS","year":"2020","unstructured":"Molina BS, Kipp HL, Joseph HM, et al.. Stimulant diversion risk among college students treated for ADHD: Primary care provider prevention training. Acad Pediatr. 2020, 20:119-27. 10.1016\/j.acap.2019.06.002","journal-title":"Acad Pediatr"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2016.08.023","article-title":"Adolescent patient education regarding ADHD stimulant diversion and misuse","volume":"100","author":"Colaneri N","year":"2017","unstructured":"Colaneri N, Keim S, Adesman A. Adolescent patient education regarding ADHD stimulant diversion and misuse. Patient Educ Couns. 2017, 100:289-96. 10.1016\/j.pec.2016.08.023","journal-title":"Patient Educ Couns"},{"key":"ref28","unstructured":"National Resident Matching Program advance data tables. 2023 main residency match. (2023). Accessed: October 5, 2023: https:\/\/www.nrmp.org\/wp-content\/uploads\/2023\/04\/Advance-Data-Tables-2023_FINAL-2.pdf."},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7340a1","article-title":"Attention-deficit\/hyperactivity disorder diagnosis, treatment, and telehealth use in adults \u2014 National Center for Health Statistics Rapid Surveys System, United States, October-November 2023","volume":"73","author":"Staley BS","year":"2024","unstructured":"Staley BS, Robinson LR, Claussen AH, et al.. Attention-deficit\/hyperactivity disorder diagnosis, treatment, and telehealth use in adults \u2014 National Center for Health Statistics Rapid Surveys System, United States, October-November 2023. MMWR Morb Mortal Wkly Rep. 2024, 73:890-5. 10.15585\/mmwr.mm7340a1","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2017.17030298","article-title":"Late-onset ADHD reconsidered with comprehensive repeated assessments between ages 10 and 25","volume":"175","author":"Sibley MH","year":"2018","unstructured":"Sibley MH, Rohde LA, Swanson JM, et al.. Late-onset ADHD reconsidered with comprehensive repeated assessments between ages 10 and 25. Am J Psychiatry. 2018, 175:140-9. 10.1176\/appi.ajp.2017.17030298","journal-title":"Am J Psychiatry"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/363977-prescribing-practices-motivations-and-behaviors-contributing-to-prescription-stimulant-misuse-among-medical-students-at-an-allopathic-medical-school-cross-sectional-survey-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T14:55:51Z","timestamp":1772722551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/363977-prescribing-practices-motivations-and-behaviors-contributing-to-prescription-stimulant-misuse-among-medical-students-at-an-allopathic-medical-school-cross-sectional-survey-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.104712","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,5]]}}}